• SENSEX 73,246.03
    -352.64 (--0.48%)
  • BANKNIFTY 54,267.40
    292.50 (+0.54%)
Back

Corporate News

Vivanza Biosciences confirms no new public funding and regulatory compliance
08-Oct-2026, 12:06

Vivanza Biosciences Limited informed the BSE Limited on October 8, 2026, that the company has not raised any further funds through a public issue, rights issue, or preferential issue, and therefore, the statement of deviation or variation under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is not applicable.